Synmosa Biopharma Corporation (4114.TWO)

TWD 31.75

(1.6%)

Operating Income Summary of Synmosa Biopharma Corporation

  • Synmosa Biopharma Corporation's latest annual operating income in 2023 was 614.74 Million TWD , down -14.3% from previous year.
  • Synmosa Biopharma Corporation's latest quarterly operating income in 2024 Q2 was 208.09 Million TWD , down -5.81% from previous quarter.
  • Synmosa Biopharma Corporation reported an annual operating income of 788 Million TWD in 2022, up 279.43% from previous year.
  • Synmosa Biopharma Corporation reported an annual operating income of 207.68 Million TWD in 2021, down -44.8% from previous year.
  • Synmosa Biopharma Corporation reported a quarterly operating income of 200 Million TWD for 2024 Q1, up 12.55% from previous quarter.
  • Synmosa Biopharma Corporation reported a quarterly operating income of 177.69 Million TWD for 2023 Q4, up 21.03% from previous quarter.

Annual Operating Income Chart of Synmosa Biopharma Corporation (2023 - 2019)

Historical Annual Operating Income of Synmosa Biopharma Corporation (2023 - 2019)

Year Operating Income Operating Income Growth
2023 614.74 Million TWD -14.3%
2022 788 Million TWD 279.43%
2021 207.68 Million TWD -44.8%
2020 376.2 Million TWD 452.57%
2019 -106.7 Million TWD 0.0%

Peer Operating Income Comparison of Synmosa Biopharma Corporation

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD -592.948%
GeneFerm Biotechnology Co., Ltd. 153.56 Million TWD -300.314%
Easywell Biomedicals, Inc. -162.73 Million TWD 477.75%
TTY Biopharm Company Limited 1.37 Billion TWD 55.208%
Orient EuroPharma Co., Ltd. 84.55 Million TWD -627.041%
Center Laboratories, Inc. -79.26 Million TWD 875.553%
Tien Liang BioTech Co., Ltd. 20.43 Million TWD -2908.133%
Orient Pharma Co., Ltd. 27.75 Million TWD -2115.047%
InnoPharmax Inc. -64.83 Million TWD 1048.105%
Johnson Chemical Pharmaceutical Works Co., Ltd. 105.57 Million TWD -482.302%
Excelsior Biopharma Inc. -81.12 Million TWD 857.743%
DV Biomed Co., Ltd. 173.54 Million TWD -254.218%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 161.009%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 11.649%
UniPharma Co., Ltd. -27.3 Million TWD 2351.39%
Anxo Pharmaceutical Co., Ltd. 53.15 Million TWD -1056.552%
Alar Pharmaceuticals Inc. 385.52 Million TWD -59.455%
Winston Medical Supply Co., Ltd. 196.1 Million TWD -213.482%
Mercury Biopharmaceutical Corporation -45.69 Million TWD 1445.463%
Bioray Biotech Co., Ltd -19.33 Million TWD 3280.084%
TSH Biopharm Corporation Limited 63.63 Million TWD -866.12%